Matthew T Campbell

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Matthew T Campbell

Aug 19, 2024, 12:16 | Insight

Talal El Zarif: After adjuvant immunotherapy, what comes next in renal cell carcinoma?

Talal El Zarif shared a post by Karl Semaan, Postdoctoral Oncology Research Fellow at Dana-Farber…

Aug 16, 2024, 14:16 | Insight

Karl Semaan: First-line systemic therapy following adjuvant immunotherapy in renal cell carcinoma

Karl Semaan, Postdoctoral Research Fellow at Dana-Farber Cancer Institute, shared a post on X: “Just…

Jul 19, 2024, 14:41 | Blog

DOR to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation

Enrique Grande shared a post on X: ''Durable Objective Response to Lurbinectedin in Small Cell…

Apr 11, 2024, 14:28 | Insight

New Paper Alert! Promising Results from Cabozantinib Phase 2 trial in advanced Adrenocortical Tumors

Promising Results from Cabozantinib Phase 2 trial in advanced Adrenocortical Tumors Authors: Matthew T Campbell,…

All: 4 Posts: 1 - 100